



* Laboratoire Cytokines, FRE 2224, IFR FR 59, IBMIG, Université de Poitiers, Cedex, France;
Laboratoire Universitaire dHématologie, EA 482, Université de Bordeaux 2, France;
Laboratoire de Physiologie, Faculté de Médecine, Université de Limoges, Cedex, France; and
Laboratoire Diaclone, BP 1985, Besançon, France
Correspondence: J. C. Lecron, Laboratoire Cytokines, FRE 2224, IFR FR 59, IBMIG, Université de Poitiers, 40, avenue du Recteur Pineau, 86022 Poitiers, Cedex, France. E-mail: Jean-Claude.Lecron{at}univ-poitiers.fr
M-CSF is a pleiotropic cytokine involved in the survival, proliferation, and differentiation of cells of the monocyte/macrophage lineage. M-CSF is produced by numerous cells including CD3-activated T cells. M-CSF serum levels are increased during acute graft rejection. We tested the in vitro production of M-CSF, GM-CSF, IL-2, and IL-4 by T-cell clones costimulated by CD3 and accessory activation pathways and the effects of cyclosporin A and methylprednisolone. The nine clones studied and CD4+ cells purified from peripheral blood mononuclear cells (PBMC) spontaneously produced low levels of M-CSF, which PMA and CD3 mAb strongly enhanced. In contrast to IL-2, CD28 mAb did not further enhance this production. CsA inhibited M-CSF production by clones and purified CD4 T cells. Addition of IL-2, anti IL-2, or anti CD25 mAb to the cultures demonstrated that CsA down-regulated M-CSF synthesis by activated T cells through its inhibition of IL-2 synthesis. These results could help to better understand the complex mechanisms of acute graft rejection and immunosuppression.
Key Words: immunosuppression graft-versus-host TNF-
PMA
This article has been cited by other articles:
![]() |
Y. Le Meur, V. Leprivey-Lorgeot, S. Mons, M. Jose, J. Dantal, B. Lemauff, J.-C. Aldigier, C. Leroux-Robert, and V. Praloran Serum levels of macrophage-colony stimulating factor (M-CSF): a marker of kidney allograft rejection Nephrol. Dial. Transplant., July 1, 2004; 19(7): 1862 - 1865. [Abstract] [Full Text] [PDF] |
||||